Venrock Healthcare Capital Partners III, L.P.

4 filings 4 distinct issuers Active 2026-06-09 → 2026-09-21

Track Record

Total filings

2 SCHEDULE 13G · 1 SCHEDULE 13D · 1 SCHEDULE 13D/A

Distinct issuers

100% issuer diversity

Median stake

9.9%

4,552,277 avg shares

AI briefs cached

0/4

intent-classified filings

Filed	Form	Issuer	Stake	Shares
2026-09-21	SCHEDULE 13G	X4 Pharmaceuticals, Inc.XFOR	—	—	view →
2026-09-15	SCHEDULE 13D	Korsana Biosciences, Inc.KRSA	9.90%	4,552,277	view →
2026-09-08	SCHEDULE 13D/A	APOGEE THERAPEUTICS, INC.	—	0	view →
2026-06-09	SCHEDULE 13G	Relmada Therapeutics, Inc.RLMD	—	—	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.